Will Muirhead

This is my first X message using my BCI. 🤯@Neuralink

Look forward to seeing you this afternoon. To find the LIHE, please use the following what3words: w3w.co/urgent.scan.mo… or use the following address: 100 Lambeth Palace Rd, London SE1 7AR See you later! 🧠🦿

We have received Breakthrough Device Designation from the FDA for Blindsight. Join us in our quest to bring back sight to those who have lost it. Apply to our Patient Registry and openings on our career page neuralink.com

🚨 Next event!! 🚨 Join us on 26th Sept 2024 at the London Institute for Healthcare Engineering Prof George Malliaras @Cambridge_Uni and Mr Jonathan Shapey @KingsCollegeLon will be speaking about all things neurotechnology 🧠 #BCI #neurotech eventbrite.co.uk/e/professor-ge…

@hugo_lh Great find Hugo! There is even a suggestion of a single unit biomarker of depression in there. @JacquesCarolan may be interested in this

Interesting progress in bio mechanisms of depression - and how treatments enhance mechanisms of neuroplasticity Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder | Molecular Psychiatry nature.com/articles/s4138…

A reminder that tickets for our next event are out! 11th July @QSNeurosurgery with Dr Dan Bush!! Details below 🧠 #BCI #neurotech

Next impact event 🚨 ‼️ Join us on the 11th July 2024 for a fantastic event with Dr Dan Bush who will be talking to us about studying memory function using intracranial EEG! 🧠 ⏰ 1630-1830 📍 Wolfson LT, 33 Queen Square, London @QSNeurosurgery eventbrite.co.uk/e/dr-daniel-bu…

We’ve just passed 100 days since the first participant in our clinical trial received his Neuralink implant. Read our latest progress update here: neuralink.com/blog/prime-stu…

Fantastic event this evening with Luke Bashford discussing Utah array clinical trials. Thanks to everyone for joining, and follow our X for news about future events. Also brilliant first time @KingsCollegeLon Inst for Healthcare Engineering + views of parliament #bci #neurotech

🚨Excited to share that our programme thesis is live!🚨 We lay out a vision for ***precision neurotech*** capable of tackling some of the most complex brain disorders at the circuit level. We believe this is possible by leveraging advances in bio- & hardware-engineering🧠🧬💻

🚨 Save the date! Join us for our next ImpaCT talk on 25th April 2024 - Dr Luke Bashford will be discussing Utah Array BCI Trials in Humans! Tickets here:eventbrite.com/e/847286565927… #neurotech #BCI #utaharray @KingsCollegeLon @kingsmedicine

25th April 2024 - Join us! 🚨 #BCI #neurotech

This is a fantastic initiative to further the clinical translational of BCI! ibci-cc.org @neuroleigh @ImpaCTNeurotech

Join us on 25th April for the next ImpaCT talk: Dr Luke Bashford will be discussing “Utah Array BCI Trials in Humans” 🧠 👀Get your tickets now! #BCI #clinicaltrials #neurotech eventbrite.com/e/847286565927… @KclNeurosoc @KCLneurosurgery @KingsCollegeLon @kingsmedicine

Some #neurotech lunchtime reading - I’ve collected nuggets of wisdom from Jörn Rickert, Andres Lozano, @WRMuirhead, @IoanaGrigoras4, @pivipivi73, Tim Denison, @mikhailshapiro, Damien Coyle, @ConorRussomanno, Penelope Lewis, Tamar Malkin, and other participants of the @royalsociety Neural Interfaces Summit 2023, and added my own (mis)interpretations/reflections about how neurotech may develop. The note covers recent developments in invasive and non-invasive neurotech, provides an estimate of what the adoption may look like, and discusses how it could be accelerated. #BCI #neuroscience #Neurosurgery #DeepTech #VentureCapital #frontiertech peterzhegin.com/investor-notes…

@PeterZhegin @IoanaGrigoras4 @pivipivi73 @mikhailshapiro @ConorRussomanno Nice summary Peter!

Incredible work from the entire team at CTRL-Labs! biorxiv.org/content/10.110…

Our next ImpaCT talk is here! Join us in person 🧠 🚨Get your tickets now for the 25th April! “Luke Bashford - Utah Array BCI Trials in Humans" eventbrite.co.uk/e/dr-luke-bash… @Eventbrite

This is the first privately held preclinical facility (large animal and cadaveric) in the neurotechnology capital of Australia: Melbourne. We grew it from nothing to a profitable and growing service-based company. The focus is on minimally invasive, endovascular and robotics technology. The facility is used for research, training and education. Australia has become globally recognised as conducting pioneering preclinical and first-in-human clinical research. @Vascu_Lab are a gateway into this ecosystem.

So many technologies emerging in this space. Great for patients. Tsinghua University put out this press release but I can't see a paper. Do we still do papers? medicalxpress.com/news/2024-02-m…